Articles

A new study reveals a promising drug reduces vision loss in Stargardt disease, showing significant safety and efficacy over 2 years.

A study shows enhanced safety and efficacy in epi-on cross-linking for keratoconus, utilizing oxygen-rich boost goggles during treatment.

At the 2025 Academy of American Ophthalmology meeting, Prof Stalmans described safety and efficacy benefits of disposable non-contact vitrectomy lenses

The investigators noted that this report is the first about subretinal drusenoid deposits in Black and Hispanic patients with age-related macular degeneration

The video-driven platform will improve workflow, education and engagement, said Inder Paul Singh, MD

The full range of vision lens debuted at the 2025 ESCRS meeting in Copenhagen

Patients with proliferative diabetic retinopathy, central retinal vein occlusion and branch retinal vein occlusion experienced fluctuating retinal perfusion, investigators reported

The agenda includes subspecialty days, evening events and partner programmes from practice management organisations

Research finding challenge the widely-held notion that cosmetic contact lenses are the safest technique for changing eye colour

A pair of studies, conducted in Taiwan and China, indicate that red light therapy could serve as an effective and safe alternative to atropine

Biomarkers and fine-tuned staging are key to progress in improving retinal care, according to Fanka Gilevska, MD, PhD

Patient response focused on perceived vision-related quality of life outcomes, investigators said

The procurement follows an 18-month pilot at a high-volume surgery in Dundee, Scotland

EyeArt uses artificial intelligence for autonomous detection of vision-threatening diabetic retinopathy

The newly-approved technology delivers low-dose microcurrents through closed eyelids to stimulate retinal cells

The current staging system fails to fully capture the neurovascular unit's status, said Stela Vujosevic, Md, PhD, FEBO

Alteogen received a positive CHMP opinion for EYLUXVI in July 2025

Leading companies spotlight innovations in cataract and refractive surgery at the 43rd ESCRS Congress in Copenhagen

At the ESCRS meeting, cataract surgeons can get familiar with BVI's Virtuoso platform and VirtuaLens' immersive VR IOL simulator

Alcon, Bausch + Lomb and Johnson & Johnson will debut new research findings during the European Society of Cataract and Refractive Surgeons Congress in Copenhagen, Denmark

Ahead of the ESCRS congress and iNovation day, we go behind the scenes with Ciliatech founder Philippe Sourdille, MD, and president Olivier Benoit

Dr Ramtohul's research uses electrophysiologic testing to study the retinal ganglion cells

The US Food and Drug Administration (FDA) also granted RMAT designation for MCO-010 in Stargardt disease (SD).

Presentation topics will include therapies for age-related macular degeneration, X-linked retinitis pigmentosa and other retinal pathologies

Clinical leaders including Susan Schneider, MD; Lejla Vajzovic, MD; and Harvey Uy, MD, will share new clinical findings

An understanding of GA growth kinetics is key to addressing the pathophysiology of age-related macular degeneration

Where to find members of our editorial board at this year's European Society of Retina Specialists Congress

Answering all the questions ophthalmologists may have ahead of the EURETINA Congress in Paris, France